TROY, Mich., March 3, 2025 /PRNewswire/ -- CACI's recent report has investors wondering if the company's stock is overvalued.

Strawberry Fields REIT (NYSE:STRW ) Q4 2024 Earnings Conference Call March 3, 2025 11:00 AM ET Company Participants Jeff Bajtner - Chief Investment Officer Greg Flamion - CFO Moishe Gubin - Chairman and CEO Conference Call Participants Gaurav Mehta - Alliance Global Partners Rob Stevenson - Janney Rich Anderson - Wedbush Securities Barry Oxford - Colliers Securities Mark Smith - Lake Street Operator Good morning, my name is Tom and I will be your conference operator today. I would like to welcome everyone to the Strawberry Fields REIT Year-End 2024 Earnings Call.

MONTERREY, Mexico, March 03, 2025 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announces it will hold its Annual Ordinary Shareholders' Meeting on April 11, 2025, in Monterrey, Nuevo Leon, Mexico (the “Shareholders' Meeting”). A copy of the formal call for the Shareholders' Meeting is available in the following link: https://femsa.gcs-web.com/shareholder-meeting-information.

XAR is an ETF holding 35 stocks, tracking the performance of the S&P® Aerospace & Defense Select Industry® Index, with an expense ratio of 0.35%. Since January, the ETF's price has declined by nearly 10%, leading to a mean reversion of the P/E ratio. State Street's 3-5 year EPS growth estimate remains at 11%. The forward P/E is at 25, in line with the 10-year average, making XAR's price, in my view, fair value.

The embattled U.S. Consumer Financial Protection Bureau on Monday asked a federal court to issue a stay in its enforcement action against Comerica Bank , court papers showed.

Fortrea Holdings Inc. (NASDAQ:FTRE ) Q4 2024 Earnings Call March 3, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Justin Bowers - DB David Windley - Jefferies Elizabeth Anderson - Evercore Luke Sergott - Barclays Eric Coldwell - Baird Max Smock - William Blair Will Ortmayer - Goldman Sachs Charles Rhyee - TD Cowen Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth …

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Semtech Corporation (NASDAQ: SMTC), a prominent high-performance, semiconductor, Internet of Things systems and cloud connectivity service provider, alleging that the company misled investors about the suitability of – and the ramp-up schedule for – its CopperEdge product portfolio. The suit, captioned Kleovoulos v. Semtech Corporation, et al., No. 2:25-cv-01474 (C.D. Cal.), represents investors who purchased or acquired Semtech securities between August 27, 2024 and February 7, 2025.

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- On February 25, 2025, the share price of Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plummeted 21% after the company announced it is delaying its Q4 and FY 2024 earnings release and said it requires additional time to complete its year-end financial close process.

NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Alarum Technologies Ltd. (NASDAQ:ALAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alarum-technologies-ltd-lawsuit-submission-form?prid=133678&wire=1 or contact Joseph E.

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSema. Hagens Berman urges investors who purchased Novo Nordisk shares and suffered substantial losses to submit your losses now.

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against The Trade Desk, Inc. (NASDAQ: TTD), a prominent advertising technology firm, alleging that the company and certain executives engaged in fraudulent practices related to the company's rollout of Kokai, a generative artificial intelligence forecasting tool that enables users to more effectively deploy advertising spend. The suit, captioned United Union of Roofers, Waterproofers & Allied Workers Local Union No. 8 WBPA Fund v. The Trade Desk, Inc. et al., No. 2:25-cv-01396 (C.D. Cal.), represents investors who purchased or acquired The Trade Desk common stock between …

Authorities in Singapore detained three people on charges of deliberately misrepresenting the final destination of U.S.-manufactured servers. The servers likely contained Nvidia's highly sought-after chips.

With Stalling Sales Growth, Super Micro's Stock Price Might Rationalize Even Further

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), represents investors who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025.

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- Investors in Crocs, Inc. (NASDAQ: CROX) suffered yet another loss on Oct. 29, 2024 after the company prepared investors for disappointing Q4 and FY 2024 financial results that, in turn, sent shares crashing $26.47 (-19%). According to the company, the culprit was its HEYDUDE operating segment performance. Now a class action lawsuit has been filed focused on the propriety of Crocs' disclosures about sales practices within its HEYDUDE operating segment, which Crocs acquired in mid-February 2022.

NEW HAVEN, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale in a registered direct offering of 4,000,000 shares (the “Shares”) of common stock, par value $0.001 per share (“Common Stock”) (or common stock equivalents in lieu thereof), and accompanying warrants (the “Accompanying Warrants”) to purchase up to 4,000,000 shares of Common Stock at a combined offering price of $3.50 per Share (or …

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI) saw its shares jump on Feb. 20, after the aerospace firm dismissed allegations made by activist short-sellers Muddy Waters and Snowcap Research as “without merit.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON DIGIMARC CORPORATION (DMRC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On February 26, 2025, Digimarc released its fourth quarter and.

Apple is planning something for "this week," according to CEO Tim Cook. His X post was concise, but it's a callback to the launch of the first MacBook Air.

NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of IonQ, Inc. ("IonQ, Inc.") (NYSE:IONQ) concerning possible violations of federal securities laws. On February 26, 2025, IONQ reported positive revenue results for Q4 2024 financial results.